Pharmacology & ToxicologyFrontiers in PharmacologyPeer-reviewed
Proteomic Assessment of SKBR3/HER2+ Breast Cancer Cellular Response to Lapatinib and Investigational Ipatasertib Kinase Inhibitors
Arba Karcini, Nicole R. Mercier, Iulia M. Lazar
This study uses proteomic analysis to evaluate the response of HER2+ breast cancer cells to Lapatinib and Ipatasertib, identifying proteins and pathways affected by these drugs.
4 citations